Outliers affecting cardiac troponin I measurement: comparison of a new high sensitivity assay with a contemporary assay on the Abbott ARCHITECT analyser
Authors:
- 20 September 2013
- journal article
- research article
- Published by SAGE Publications in Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
- Vol. 51 (4) , 476-484
Abstract
Background: False-positive cardiac troponin (Tn) results caused by outliers have been reported on various analytical platforms. We have compared the precision profile and outlier rate of the Abbott Diagnostics contemporary troponin I (TnI) assay with their high sensitivity (hs) TnI assay. Methods: Three studies were conducted over a 10-month period using routine patients’ samples. TnI was measured in duplicate using the contemporary TnI assay in Study 1 and Study 2 ( n = 7011 and 7089) and the hs–TnI assay in Study 3 ( n = 1522). Critical outliers were defined as duplicate results whose absolute difference exceeded a critical difference (CD = z x √2 x SD Analytical ) at a probability level of 0.0005, with one of the results on the opposite side of the decision limit to its partner. Results: The TnI concentration at 10% imprecision (coefficient of variation) for the contemporary TnI assay was 0.034 µg/L (Study 1) and 0.042 µg/L (Study 2), and 0.006 µg/L (6 ng/L) for the hs–TnI assay. The critical outlier rates for the contemporary TnI assay were 0.51% (Study 1) and 0.37% (Study 2) using a cut-off of 0.04 µg/L, and 0% for the hs–TnI assay using gender-specific cut-offs. Conclusion: The significant number of critical outliers detected using the contemporary TnI assay may pose a risk for misclassification of patients. By contrast, no critical outliers were detected using the hs–TnI assay. However, the total outlier rates for both assays were significantly higher than the expected variability of either assay. The cause of these outliers remains unclear.Keywords
This publication has 21 references indexed in Scilit:
- Analytical Characteristics of High-Sensitivity Cardiac Troponin AssaysClinical Chemistry, 2012
- Outliers as a Cause of False Cardiac Troponin Results: Investigating the Robustness of 4 Contemporary AssaysClinical Chemistry, 2011
- Comparison of high sensitivity and contemporary troponin assays for the early detection of acute myocardial infarction in the emergency departmentAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2011
- High sensitivity troponin outperforms contemporary assays in predicting major adverse cardiac events up to two years in patients with chest painAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2011
- 2011 Addendum to the Guidelines for the Management of Acute Coronary Syndromes 2006Heart, Lung and Circulation, 2011
- Falsely elevated troponin I results due to outliers indicate a lack of analytical robustnessAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2010
- A New Season for Cardiac Troponin Assays: It’s Time to Keep a ScorecardClinical Chemistry, 2009
- National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical Issues for Biochemical Markers of Acute Coronary SyndromesClinical Chemistry, 2007
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary SyndromesClinical Chemistry, 2007
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarctionJACC, 2000